secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLIANT THERAPEUTICS, INC. (PLRX)
CIK:        0001746473
Form:       8-K
Filed at:   2026-03-03T23:59:59+00:00
Accession:  0001746473-26-000024
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pliant Therapeutics extends poison pill expiration to March 2027
----------------------------------------------------------------

- Extended stockholder rights agreement expiration from March 11, 2026 to March 11, 2027.
- Amendment entered with Computershare Trust Company on March 3, 2026.
- Company states the extension is not in response to any specific takeover offer.
- Rights may still be earlier redeemed, exchanged or terminated per original terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1746473/000174647326000024/0001746473-26-000024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1746473/000174647326000024/plrx-20260303.htm
  HTML page:      https://secwatch.observer/filing/0001746473-26-000024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer